Annals of the Rheumatic Diseases: 72 (11)

Editorial

Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced? (9 August, 2013) Free
Patrick H Dessein, Anne G Semb

Criteria

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative (3 October, 2013)
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira, Gabriela Riemekasten, Philip J Clements, Christopher P Denton, Oliver Distler, Yannick Allanore, Daniel E Furst, Armando Gabrielli, Maureen D Mayes, Jacob M van Laar, James R Seibold, Laszlo Czirjak, Virginia D Steen, Murat Inanc, Otylia Kowal-Bielecka, Ulf Müller-Ladner, Gabriele Valentini, Douglas J Veale, Madelon C Vonk, Ulrich A Walker, Lorinda Chung, David H Collier, Mary Ellen Csuka, Barri J Fessler, Serena Guiducci, Ariane Herrick, Vivien M Hsu, Sergio Jimenez, Bashar Kahaleh, Peter A Merkel, Stanislav Sierakowski, Richard M Silver, Robert W Simms, John Varga, Janet E Pope

Review

Value of biomarkers in osteoarthritis: current status and perspectives (29 July, 2013)
M Lotz, J Martel-Pelletier, C Christiansen, M-L Brandi, O Bruyère, R Chapurlat, J Collette, C Cooper, G Giacovelli, J A Kanis, M A Karsdal, V Kraus, W F Lems, I Meulenbelt, J-P Pelletier, J-P Raynauld, S Reiter-Niesert, R Rizzoli, L J Sandell, W E Van Spil, J-Y Reginster

Clinical and epidemiological research

Extended report: Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis (13 July, 2013) Free
Alfonso Corrales, José A Parra, Carlos González-Juanatey, Javier Rueda-Gotor, Ricardo Blanco, Javier Llorca, Miguel A González-Gay
Extended report: Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations (12 July, 2013) Free
Jette Primdahl, Joan Clausen, Kim Hørslev-Petersen
Extended report: Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study (17 November, 2012)
Arthur Kavanaugh, Iain B McInnes, Philip J Mease, Gerald G Krueger, Dafna D Gladman, Désirée van der Heijde, Surekha Mudivarthy, Weichun Xu, Michael Mack, Zhenhua Xu, Anna Beutler
Extended report: Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study) (10 November, 2012)
Nathalie Costedoat-Chalumeau, Lionel Galicier, Olivier Aumaître, Camille Francès, Véronique Le Guern, Frédéric Lioté, Amar Smail, Nicolas Limal, Laurent Perard, Hélène Desmurs-Clavel, Du Le Thi Huong Boutin, Bouchra Asli, Jean-Emmanuel Kahn, Jacques Pourrat, Laurent Sailler, Félix Ackermann, Thomas Papo, Karim Sacré, Olivier Fain, Jerome Stirnemann, Patrice Cacoub, Moez Jallouli, Gaelle Leroux, Judith Cohen-Bittan, Marie-Laure Tanguy, Jean-Sébastien Hulot, Philippe Lechat, Lucile Musset, Zahir Amoura, Jean-Charles Piette, on behalf of Group PLUS
Extended report: Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis (8 November, 2012)
Jacqueline E Paramarta, Leen De Rycke, Tanja F Heijda, Carmen A Ambarus, Koen Vos, Huib J Dinant, Paul P Tak, Dominique L Baeten
Extended report: Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study (23 November, 2012)
Aatke van der Maas, Elisabeth Lie, Robin Christensen, Ernest Choy, Yaël A de Man, Piet van Riel, Thasia Woodworth, Alfons A den Broeder
Extended report: Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons (21 November, 2012)
Marieke H Otten, Janneke Anink, Sandra Spronk, Lisette W A van Suijlekom-Smit
Extended report: Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist (15 November, 2012)
Daniel H Solomon, Jeremy A Rassen, Bindee Kuriya, Lang Chen, Leslie R Harrold, David J Graham, James D Lewis, Joyce Lii, Liyan Liu, Marie R Griffin, J R Curtis
Extended report: Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis (15 November, 2012)
Antonios Stavropoulos-Kalinoglou, Giorgos S Metsios, Jet JJCS Veldhuijzen van Zanten, Peter Nightingale, George D Kitas, Yiannis Koutedakis
Extended report: Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis (23 November, 2012)
Anne M Kerola, Tuomas Kerola, Markku J Kauppi, Hannu Kautiainen, Lauri J Virta, Kari Puolakka, Tuomo V M Nieminen
Extended report: Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial (21 November, 2012)
Robert Zimmer, Hugo R Scherbarth, Oscar Luis Rillo, Juan Jesus Gomez-Reino, Sylviane Muller
Concise report: Extent and distribution of CPP deposits in patients affected by calcium pyrophosphate dihydrate deposition disease: an ultrasonographic study (26 March, 2013)
Georgios Filippou, Emilio Filippucci, Marika Tardella, Ilaria Bertoldi, Marco Di Carlo, Antonella Adinolfi, Walter Grassi, Bruno Frediani
Concise report: Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study (5 April, 2013)
Karen Minde Fagerli, Elisabeth Lie, Désirée van der Heijde, Marte Schrumpf Heiberg, Synøve Kalstad, Erik Rødevand, Knut Mikkelsen, Åse Stavland Lexberg, Tore K Kvien

Basic and translational research

Extended report: Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma (20 February, 2013)
Giuseppina Abignano, Sibel Zehra Aydin, Concepción Castillo-Gallego, Vasiliki Liakouli, Daniel Woods, Adam Meekings, Richard J Wakefield, Dennis G McGonagle, Paul Emery, Francesco Del Galdo
Extended report:
NKG₂D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica
(15 February, 2013)
Christian Dejaco, Christina Duftner, Juman Al-Massad, Annette D Wagner, Joon-Keun Park, Johannes Fessler, Ariane Aigelsreiter, Franz Hafner, Sandra Vega, William Sterlacci, Beatrix Grubeck-Loebenstein, Alexander Tzankov, Thomas Ness, Luigi Boiardi, Carlo Salvarani, Michael Schirmer
Extended report: Interleukin-1 receptor antagonist deficient mice provide insights into pathogenesis of human intervertebral disc degeneration (9 February, 2013)
Kate Louise Eve Phillips, Nikki Jordan-Mahy, Martin J H Nicklin, Christine Lyn Le Maitre
Extended report:
Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load
(24 January, 2013)
Nicola Dalbeth, Meaghan E House, Gregory D Gamble, Anne Horne, Bregina Pool, Lauren Purvis, Angela Stewart, Marilyn Merriman, Murray Cadzow, Amanda Phipps-Green, Tony R Merriman
Extended report: Regulation of matrixmetalloproteinase-3 and matrixmetalloproteinase-13 by SUMO-2/3 through the transcription factor NF-κB (16 February, 2013)
Svetlana Frank, Marvin A Peters, Corinna Wehmeyer, Simon Strietholt, Christina Koers-Wunrau, Jessica Bertrand, Marianne Heitzmann, Anja Hillmann, Joanna Sherwood, Christine Seyfert, Steffen Gay, Thomas Pap
Concise report:
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
(14 August, 2013)
A Serrano, A Márquez, S L Mackie, F D Carmona, R Solans, J A Miranda-Filloy, J Hernández-Rodríguez, M C Cid, S Castañeda, IC Morado, J Narváez, R Blanco, B Sopeña, M J García-Villanueva, J Monfort, N Ortego-Centeno, A Unzurrunzaga, B Marí-Alfonso, J Sánchez-Martín, E de Miguel, C Magro, E Raya, N Braun, J Latus, O Molberg, B A Lie, F Moosig, T Witte, A W Morgan, M A González-Gay, J Martín, UK GCA Consortium Spanish GCA Consortium

Letters

Classification of vasculitis: EMA classification using CHCC 2012 definitions (1 June, 2013)
Rita Abdulkader, Suzanne E Lane, David G I Scott, Richard A Watts
The timing of serum infliximab loss, or the appearance of antibodies to infliximab (ATI), is related with the clinical activity in ATI-positive patients with rheumatoid arthritis treated with infliximab (5 June, 2013)
Ch Plasencia, D Pascual-Salcedo, P Alcocer, M G Bonilla, A Villalba, D Peiteado, F Arribas, J Díez, M T Lopez-Casla, E Martín-Mola, A Balsa

Electronic pages

Letter: Is early remission associated with improved survival or is arthritis persistency associated with increased mortality in early arthritis? Comparisons with the general population (12 July, 2013)
Jessica A B van Nies, Annette H M van der Helm-van Mil
Letter:
Response to ‘In erosive hand osteoarthritis more inflammatory signs on ultrasound are found than in the rest of hand osteoarthritis’ by Kortekaas et al
(19 July, 2013)
Ai Lyn Tan, Andrew Grainger, Dennis McGonagle
Letter: Abatacept in relapsing polychondritis (16 August, 2013)
Guillaume Moulis, Grégory Pugnet, Laurent Sailler, Leonardo Astudillo, Philippe Arlet
Letter:
Response to ‘Abatacept in relapsing polychondritis’ by Moulis et al
(21 August, 2013)
Stanford L Peng, Donald Rodriguez

Main menu

Table of contents

November 2013 - Volume 72 - 11

Editorial

Criteria

Review

Clinical and epidemiological research

Basic and translational research

Letters

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

November 2013 - Volume 72 - 11

Editorial

Criteria

Review

Clinical and epidemiological research

Basic and translational research

Letters

Electronic pages

Issue Information